Friday 6 November 2026 Export EXEL’s income statement to Excel — free account

Exelixis, Inc.

EXEL Healthcare Biotechnology

Exelixis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.98% from fiscal 2024.

Revenue: +10.2%
EPS: +22.2%
Free cash flow: −4.83%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

69.55 0.84 +1.22%

Follow EXEL

Alert me

Market cap: $16.8B
P/E: 19.9×
Fwd P/E: 20.2×
Dividend yield: —
F-score: 7/9
Altman Z: 12.68
Beneish M: −2.61
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	15.17	13.70	16.49	16.88
P/S ratio Full definition →		5.13	4.66	5.60	5.77
P/FCF ratio Full definition →		14.10	12.24	11.78	12.59
P/Operating CF Full definition →		35.69	43.99	44.34	51.48
P/B ratio Full definition →		5.51	5.72	7.40	7.86
Price to Tangible BV Full definition →		5.67	5.92	7.67	8.14
EV/Sales Full definition →		4.68	4.35	5.27	5.42
EV/EBITDA Full definition →		12.06	10.70	12.83	13.13
EV/Operating CF Full definition →		12.29	11.17	10.84	11.55
EV/FCF Full definition →		12.87	11.41	11.08	11.83
Quick Ratio Full definition →		3.32	2.98	3.21	2.96
Current Ratio Full definition →		3.56	3.26	3.46	3.21
Net Debt/EBITDA Full definition →		(4.37)	(3.01)	(3.29)	(3.24)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.80	0.87	0.94	0.94
Operating CF/Net income Full definition →		1.36	1.20	1.45	1.28
Capex/Depreciation Full definition →		(1.03)	(0.29)	(1.33)	(1.45)
Research and Development Expense of Revenue Full definition →		35.62%	32.73%	33.72%	31.80%
Selling, General and Administrative Expense of Revenue Full definition →		20.55%	22.86%	23.48%	23.46%
Intangible Assets out of Total Assets Full definition →		0.02	0.02	0.03	0.03
Share Based Compensation of Revenue Full definition →		3.36%	4.76%	5.18%	4.36%
Graham Net Nets Full definition →		0.06	0.05	0.04	0.04
Graham Number Full definition →		22.75	22.97	23.36	24.05
Earnings Yield Full definition →		6.59%	7.30%	6.07%	5.92%
Free Cash Flow Yield Full definition →		7.09%	8.17%	8.49%	7.94%
Revenue per Share Full definition →		2.20	2.36	2.51	2.67
Operating CF per Share Full definition →		1.23	0.97	1.23	1.13
Capex per Share Full definition →		(0.03)	(0.01)	(0.04)	(0.04)
Free Cash Flow per Share Full definition →		1.20	0.97	1.19	1.09
Cash per Share Full definition →		3.90	3.01	3.35	3.62
Shareholders Equity per Share Full definition →		7.96	7.49	7.35	7.43
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		7.96	7.49	7.35	7.43
Free Cash Flow Full definition →		326.36	249.81	298.43	269.89
Working Capital Full definition →		1,037.65	837.66	888.90	909.75
Capital Expenditures Full definition →		(7.16)	(2.03)	(9.32)	(10.06)
Net Current Asset Value Full definition →		760.19	550.79	600.35	641.97
EV/EBIT Full definition →		12.46	11.02	13.21	13.50
Capex to Sales Full definition →		0.01	0.00	0.01	0.02
Price to Operating Income Full definition →		13.65	11.83	14.05	14.36
Other line items
Average Receivables Full definition →		276.18	305.29	307.28	319.10
Average Payables Full definition →		33.91	33.50	32.44	28.09
Average Inventory Full definition →		22.04	25.73	26.11	28.64
Average Assets Full definition →		2,896.06	2,715.42	2,586.16	2,668.52
Average Common Equity Full definition →		2,202.76	2,033.39	1,938.65	1,997.27

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly